Showing results (2781-2790 of 6,780) with videos related to
Sort By:
Pageof 678
Clinical Therapeutics|October 4, 2005
Acute interstitial nephritis associated with moxifloxacin useMichael Argirov, Gesa Ricken, Daniel Zecher, et al.Clinical Therapeutics|February 14, 2007
Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitisAdelaide A HebertClinical Therapeutics|February 14, 2007
A meta-analysis of broad-spectrum antibiotic therapy in patients with active Crohn's diseaseRoja Rahimi, Shekoufeh Nikfar, Ali Rezaie, et al.Clinical Therapeutics|February 14, 2007
Ranolazine for the management of coronary artery diseaseJudy W M ChengClinical Therapeutics|February 14, 2007
Lubiprostone: chloride channel activator for chronic constipationAnastasia Rivkin, Larisa ChaganClinical Therapeutics|February 14, 2007
Pharmacokinetic and pharmacodynamic properties of tramadol IR and SR in elderly patients: a prospective, age-group-controlled studyRudolf Likar, Martina Wittels, Mario Molnar, et al.Clinical Therapeutics|February 14, 2007
Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trialEun Young Lee, Eun Bong Lee, Byung Joo Park, et al.Clinical Therapeutics|February 14, 2007
The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trialsJuan José Granizo, María José Giménez, José Barberán, et al.Clinical Therapeutics|February 14, 2007
Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediate-and extended-release formulations in healthy subjectsJean-Francois Marier, Murray P Ducharme, Marika DiMarco, et al.Clinical Therapeutics|December 13, 2006
A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertensionGilbert W Gleim, Joseph Rubino, Hongyan Zhang, et al.Pageof 678